Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on breast cancer risk: A meta-analysis and re-analysis of systematic meta-analyses
- PMID: 32155154
- PMCID: PMC7064184
- DOI: 10.1371/journal.pone.0216147
Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on breast cancer risk: A meta-analysis and re-analysis of systematic meta-analyses
Abstract
Background: Fourteen previous meta-analyses have been published to analyze the polymorphisms of individual GSTM1 present/null, GSTT1 present/null, and GSTP1 IIe105Val on breast cancer (BC) risk. However, their meta-analyses did not explore the combined effects of the three genetic polymorphisms on BC risk. In addition, they did not evaluate the credibility of statistically significant associations. Furthermore, a multitude of new articles have been published on these themes, and therefore a meta-analysis and re-analysis of systematic previous meta-analyses were performed to further explore these issues.
Objectives: To determine the association between the individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on breast cancer risk.
Methods: Crude odds ratios (ORs) and their 95% confidence intervals (CIs) were applied to estimate the association between individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on BC risk. To evaluate the credibility of statistically significant associations in the current and previous meta-analyses, we applied the the false-positive report probabilities (FPRP) test and the Venice criteria.
Results: 101 publications were selected to evaluate the individual and combined effects of GSTM1, GSTT1 and GSTP1 polymorphisms on BC risk. Overall, statistically significant elevated BC risk was found in any individual and combined effects of GSTM1 present/null, GSTT1 present/null, and GSTP1 IIe105Val polymorphisms. However, when we restricted studies only involving with high-quality, matching, HWE, and genotyping examination performed blindly or with quality control, significantly increased BC risk was only found in overall population for GSTM1 null genotype, among all populations, Caucasians, and postmenopausal women for the combined effects of GSTM1 and GSTT1 polymorphisms, and in overall analysis for the combined effects of GSTM1, GSTT1, and GSTP1 IIe105Val polymorphisms. Further, less-credible positive results were identified when we evaluated the credibility of positive results of the current and previous meta-analyses.
Conclusions: This meta-analysis indicates that the individual and combined effects of GSTM1, GSTT1 and GSTP1 polymorphisms may be not associated with increased BC risk.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on lung cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.Medicine (Baltimore). 2021 Jul 2;100(26):e26104. doi: 10.1097/MD.0000000000026104. Medicine (Baltimore). 2021. PMID: 34190143 Free PMC article.
-
Individual and combined effects of the GSTM1, GSTT1, and GSTP1 polymorphisms on type 2 diabetes mellitus risk: A systematic review and meta-analysis.Front Genet. 2022 Nov 7;13:959291. doi: 10.3389/fgene.2022.959291. eCollection 2022. Front Genet. 2022. PMID: 36419826 Free PMC article.
-
GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis.Cancer Chemother Pharmacol. 2016 Dec;78(6):1163-1173. doi: 10.1007/s00280-016-3173-9. Epub 2016 Oct 26. Cancer Chemother Pharmacol. 2016. PMID: 27785604
-
Individual and combined effects of the GSTM1, GSTT1, and GSTP1 polymorphisms on leukemia risk: An updated meta-analysis.Front Genet. 2022 Oct 31;13:976673. doi: 10.3389/fgene.2022.976673. eCollection 2022. Front Genet. 2022. PMID: 36386807 Free PMC article.
-
Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studies.PLoS One. 2012;7(11):e50587. doi: 10.1371/journal.pone.0050587. Epub 2012 Nov 26. PLoS One. 2012. PMID: 23189206 Free PMC article.
Cited by
-
Association of GSTP1 p.Ile105Val (rs1695, c.313A > G) Variant with the Risk of Breast Carcinoma among Egyptian Women.Biochem Genet. 2021 Dec;59(6):1487-1505. doi: 10.1007/s10528-021-10070-x. Epub 2021 May 3. Biochem Genet. 2021. PMID: 33939082
-
Impact of xenobiotic-metabolizing gene polymorphisms on breast cancer risk in South Indian women.Breast Cancer Res Treat. 2021 Apr;186(3):823-837. doi: 10.1007/s10549-020-06028-z. Epub 2021 Jan 4. Breast Cancer Res Treat. 2021. PMID: 33392841
-
Genetic Variability of Antioxidative Mechanisms and Cardiotoxicity after Adjuvant Radiotherapy in HER2-Positive Breast Cancer Patients.Dis Markers. 2020 Dec 19;2020:6645588. doi: 10.1155/2020/6645588. eCollection 2020. Dis Markers. 2020. PMID: 33425072 Free PMC article. Clinical Trial.
-
JHDM1D-AS1-driven inhibition of miR-940 releases ARTN expression to induce breast carcinogenesis.Clin Transl Oncol. 2023 Jul;25(7):2192-2203. doi: 10.1007/s12094-023-03102-y. Epub 2023 Mar 2. Clin Transl Oncol. 2023. PMID: 36862282
-
Identification of target proteins for breast cancer genetic risk loci and blood risk biomarkers in a large study by integrating genomic and proteomic data.Int J Cancer. 2023 Jun 1;152(11):2314-2320. doi: 10.1002/ijc.34472. Epub 2023 Feb 21. Int J Cancer. 2023. PMID: 36779764 Free PMC article.
References
-
- Miller JW, King JB, Joseph DA, Richardson LC. cancer screening among adult women-behavioral risk factor surveillance system, United States, 2010. MMWR Morb. Mortal Wkly Rep. 2012;61:46–50. - PubMed
-
- Ng EH, Gao F, Ji CY, Ho GH, Soo KC. Risk factors for breast carcinoma in Singaporean Chinese women: the role of central obesity. Cancer. 1997;80:725–31. - PubMed
-
- Gómez Flores-Ramos L, Escoto-De Dios A, Puebla-Pérez AM, Figuera-Villanueva LE, Ramos-Silva A, Ramírez-Patiño R, et al. Association of the tumor necrosis factor-alpha -308G > A polymorphism with breast cancer in Mexican women. Genet Mol Res. 2013;12:5680–93. 10.4238/2013.November.18.17 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous